Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOA2 Antikörper (AA 28-56)

APOA2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB15149 unconjugated
Produktnummer ABIN1882063
  • Target Alle APOA2 Antikörper anzeigen
    APOA2 (Apolipoprotein A-II (APOA2))
    Bindungsspezifität
    • 20
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 28-56
    Reaktivität
    • 77
    • 37
    • 14
    • 9
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 65
    • 11
    • 9
    • 2
    • 2
    • 1
    Kaninchen
    Klonalität
    • 72
    • 18
    Polyklonal
    Konjugat
    • 39
    • 12
    • 8
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser APOA2 Antikörper ist unkonjugiert
    Applikation
    • 41
    • 31
    • 26
    • 14
    • 13
    • 9
    • 9
    • 8
    • 8
    • 7
    • 6
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Homologie
    Pr
    Aufreinigung
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogen
    This APOA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 28-56 amino acids from the Central region of human APOA2.
    Klon
    RB15149
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product APOA2 Primärantikörper
  • Applikationshinweise
    WB: 1:1000. IHC-P: 1:10~50
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Haltbarkeit
    6 months
  • Duesing, Charpentier, Marre, Tichet, Hercberg, Balkau, Froguel, Gibson: "Evaluating the association of common APOA2 variants with type 2 diabetes." in: BMC medical genetics, Vol. 10, pp. 13, (2009) (PubMed).

    Atta, Crook, Shafique, Johnston, Godsland: "Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II." in: Thrombosis and haemostasis, Vol. 100, Issue 3, pp. 391-6, (2008) (PubMed).

  • Target
    APOA2 (Apolipoprotein A-II (APOA2))
    Andere Bezeichnung
    APOA2 (APOA2 Produkte)
    Synonyme
    Apo-AII antikoerper, ApoA-II antikoerper, apoAII antikoerper, Alp-2 antikoerper, ApoAII antikoerper, Apoa-2 antikoerper, Hdl-1 antikoerper, APOAII antikoerper, apoa2 antikoerper, apoA-II antikoerper, cb1032 antikoerper, wu:fb57h11 antikoerper, zgc:193613 antikoerper, apolipoprotein A2 antikoerper, apolipoprotein A-II antikoerper, APOA2 antikoerper, Apoa2 antikoerper, apoa2 antikoerper
    Hintergrund
    APOA2, apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia.
    Molekulargewicht
    11175
    NCBI Accession
    NP_001634
    UniProt
    P02652
    Pathways
    Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Sie sind hier:
Kundenservice